These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8102215)

  • 21. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
    Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
    Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early inflammatory arthritis versus rheumatoid arthritis.
    Finckh A
    Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
    Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
    Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug-induced remission in the severe progressive variant of rheumatoid arthritis].
    Krel' AA; Semenova OIu; Kanevskaia MZ; Shekhter AB
    Ter Arkh; 1994; 66(1):24-9. PubMed ID: 8146788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and management of rheumatoid arthritis in the general population of Greece--the ESORDIG study.
    Andrianakos A; Trontzas P; Christoyannis F; Kaskani E; Nikolia Z; Tavaniotou E; Georgountzos A; Krachtis P;
    Rheumatology (Oxford); 2006 Dec; 45(12):1549-54. PubMed ID: 16690763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining rheumatologists' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index.
    Carter JD; Lodhi AB; Nagda SR; Ricca L; Ward C; Traina E; Thompson ZJ; Huang Y; Valeriano J; Vasey FB
    J Rheumatol; 2007 May; 34(5):958-63. PubMed ID: 17407221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
    Yamaguchi Y; Yamamoto K
    Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
    Zink A; Listing J; Ziemer S; Zeidler H;
    J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remodeling the pyramid--a concept whose time has come.
    Wilske KR; Healey LA
    J Rheumatol; 1989 May; 16(5):565-7. PubMed ID: 2754660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Does the general strategy for the treatment of rheumatoid polyarthritis need to be reviewed?].
    Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Apr; 57(3 ( Pt 2)):292-6. PubMed ID: 1971456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid arthritis.
    Dorwart BB
    Prim Care; 1984 Jun; 11(2):233-41. PubMed ID: 6566359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update: slow acting anti-rheumatic drugs in rheumatoid arthritis.
    Riedemann JP; Cardiel MH; Tugwell P
    Compr Ther; 1991 Jun; 17(6):61-8. PubMed ID: 1934990
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).
    van Gestel AM; Haagsma CJ; Furst DE; van Riel PL
    Baillieres Clin Rheumatol; 1997 Feb; 11(1):65-82. PubMed ID: 9088525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arthritis of recent onset. A guide to evaluation and initial therapy for primary care physicians.
    Schumacher HR
    Postgrad Med; 1995 Apr; 97(4):52-4, 57-9, 63. PubMed ID: 7716092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid nodules do not predict response to treatment with slow-acting anti-rheumatic drugs.
    Hall GM; Studnicke A; Huskisson EC; Scott DL
    Clin Rheumatol; 1991 Dec; 10(4):384-7. PubMed ID: 1802492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of standard slow-acting antirheumatic drugs.
    Epstein WV
    Semin Arthritis Rheum; 1994 Jun; 23(6 Suppl 2):32-8. PubMed ID: 7939729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug targeting systems for inflammatory disease: one for all, all for one.
    Crielaard BJ; Lammers T; Schiffelers RM; Storm G
    J Control Release; 2012 Jul; 161(2):225-34. PubMed ID: 22226771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.